Lyra Therapeutics Announces Two Presentations at Upcoming COSM 2022
/PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,...
Source: prnewswire.com